お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
921859

世界の心房細動手術市場:成長、動向、および予測(2020年~2025年)

Atrial Fibrillation Surgery Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
世界の心房細動手術市場:成長、動向、および予測(2020年~2025年)
出版日: 2020年06月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

心臓病は世界における主な死因であり、ライフスタイルとストレスの変化や肥満により、心臓病に苦しむ人々の数は急速に増加しています。心臓病患者の症例が増加に伴い心房細動の症例数も増加しており、治療の高コストによりさまざまな国の経済に大きな負担をかけてることなどは、世界の心房細動手術市場の成長要因として挙げられます。

当レポートは世界の心房細動手術市場について調査しており、市場機会や動向、成長および阻害要因、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 肥満の増加率
    • 心臓病の治療費負担の増加
    • 国民の意識を高めるプログラムの増加
  • 市場阻害要因
    • 治療の高いコスト
    • デバイスに関連する規制の問題
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • カテーテルアブレーション
    • 外科的アブレーション
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Boston Scientific Corporation
    • Medtronic Plc
    • Biotronik
    • AtriCure, Inc.
    • Cardiofocus, Inc.
    • Abbott Laboratories
    • Advansta, Inc.

第7章 市場機会および今後の動向

目次
Product Code: 67135

The market studied is majorly driven by the factor such as the rising prevalence of obesity and the growing burden of heart diseases across the globe. In addition, heart diseases are the major cause of death across the globe and due to the changing lifestyle and stress, the number of people suffering from heart diseases is increasing rapidly.

Due to the growing cases of heart patients, there is a rise in the number of cases of atrial fibrillation and this is posing a high burden of the economies of various countries as the cost of treatment is higher. Hence, owing to the aforementioned statements, the market studied is expected to grow in the forecast period.

Key Market Trends

Ambulatory Surgical Center Segment is Expected to be the Fastest Growing Segment over the Forecast Period

The ambulatory surgical center segment is expected to be the fastest growing segment owing to the enhanced healthcare infrastructure, availability of skilled labor, and affordability. The rise in patient pool, owing to substantial growth in the geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is expected to enhance revenue generations. Moreover, compared to conventional surgeries, the benefits of minimally invasive surgeries such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time are encouraging more patients to opt for MIS surgeries, which is expected to boost the market growth.

Furthermore, due to the rising burden of obesity, there is an increase in the number of people suffering from atrial fibrillation among such population. Hence, it is believed that an increased prevalence of obesity is contributing to the growth of the market.

North America is the Largest Growing Segment over the Forecast Period

The United States holds the largest share of the atrial fibrillation market. This is majorly attributed to a large number of people suffering from this disease in the country and the presence of key players. As per the statistics provide by the CDC (Centre for Disease Control and Prevention), there were around 2.7-6.1 million people in the United States have AFib in year 2017 and with the rising geriatric population, it is expected that this number will grow in the future. As stated by the American Heart Association, high blood pressure which is one of the leading causes of atrial fibrillation accounts for around 14% to 22% of all AFib cases in the country as of 2018.

With the presence of key players in the country and availability of favorable insurance policies, people across the country are able to get the surgery done at low costs which are augmenting the growth of the market studied in the United States.

Competitive Landscape

The market for atrial fibrillation is moderately competitive and consists of local as well as global companies. Most of the developed countries are being dominated by international players whereas, developing countries are witnessing the penetration of new entrants in the market. With the technological advancements and the focus of developing economies on improving the healthcare system, it is expected that more companies will enter the market and hold a substantial share in the future.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Obesity and Heart Diseases
    • 4.2.2 Rising Number of Programs to Enhance Public Awareness
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedure
    • 4.3.2 Regulatory Issues Associated with the Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Catheter Ablation
    • 5.1.2 Surgical Ablation
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Medtronic Plc
    • 6.1.3 Biotronik
    • 6.1.4 AtriCure, Inc.
    • 6.1.5 Cardiofocus, Inc.
    • 6.1.6 Abbott Laboratories
    • 6.1.7 Advansta, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.